Injection reduces Heart Attack: The cases of fatal diseases like heart attack, and stroke are increasing rapidly. In a young age itself, the news of many cases of heart attack is seen and heard. Sometimes someone gets a heart attack while doing gym, then many reach death while dancing. According to WHO, 1.28 billion people worldwide have high blood pressure. Half of them do not even know that they have high BP. Its result suddenly comes in the form of a heart attack. However, high blood pressure is not the only reason for heart attack or stroke. There are many reasons for this but mainly lifestyle-related mistakes are responsible for this. Research is going on all over the world to prevent sudden deaths due to these deadly diseases. Now in new research, it has been claimed that by taking one injection, the risk of heart attack or stroke can be reduced by up to 20 percent.
Testing on people over 45
According to the Diabetes Community website, the pharmaceutical company Novo Nordisk is conducting research on reducing the risk of heart attack with the weight loss injection Vegovy, which is taken once a week. In this, Vegovi injection is being given to overweight people above 45 years once a week. In this, the risk of heart attack is seen to be decreasing. Amazing results of injection have been seen in limited trials. It has been found in the trial that the risk of cardiovascular diseases is reduced by 20 percent in people who inject Vigovi. That is, the risk of fatal diseases like heart attack and stroke is averted to a great extent.
Revolutionary changes are expected in the treatment of obesity and heart disease
People who are very overweight are at high risk of a heart attack. Because due to this, high blood pressure and other heart-related complications increase. Novo Nordisk believes that Vigovi injection can solve this problem in obese people. The company believes that this also reduces weight and also reduces the risk of heart attack. In a limited trial, this injection has been tested on 17 thousand people. The company's scientists expected that this injection would reduce the risk of heart attack by 15 to 17 percent, but as a result, it reduced by 20 percent. With this medicine, a new ray of hope is visible in America and Europe.
The company's Vice President Martin Holst Long has claimed that this injection will prove to be important in the treatment of obesity and diagnosing the risk of heart attack due to it. The company has now decided to apply for the approval process for this drug from the drug regulators in the US and Europe.
